Replies to post #105189 on NanoViricides Inc. (NNVC)

[NewMoney]

That is clearly very possible.

[FORZANANO]

When I said it has been a "helluva year", I meant it!

Email exchange with Dr Seymour to me:

Uplisting to a national exchange, raising of $27M for a total of $42M, a very desirable contract with USAMRIID for EbolaCide testing, creation of multiple candidates of a drug for Ebola, an innovation award for FluCide, as well as construction of a state of the art manufacturing facility. Also, initiation of toxicology studies on FluCide, progressive scale-up of FluCide samples and further demonstration of the safety of the drug candidate in animals!

Remember, we're creating new science here that can't be done overnight. Once the scale-up to 100 liter batches per bioreactor is completed, it's done! This then allows for production of much larger amounts in a much shorter time frame. The Shelton facility can handle multiple 100 liter capacity bioreactors.

You have no idea how laborious a task it is to do the scale-up. Fortunately, we've been able to hire qualified people who will help speed up the process

Also, there are all these complaints about the 200 grams we sent BASI for the start of the tox studies. That's all they needed. They will ask for more for large animals once the small animal studies are completed. We will then make it.

Also, the dates listed for human trials in the US don't mean that those will be the first FluCide trials. We've said many times that the FluCide trials will start much earlier in Australia because the bureaucratic restrictions are much less. We've stated that US trials will commence after successful sale of FluCide in jurisdictions outside of the U.S.

We simply use the U.S. as a reference point that everyone understands.

In addition, I've said many times that the availability of sale of FluCide in the EU and UK if it successfully completes initial Phase I/IIa trials is a tremendous boon to the company and may well result in a significant income stream.

So now you should understand why I feel it's been "a helluva year"

Sincerely,

Eugene Seymour, MD MPH
Chief Executive Officer
NanoViricides, Inc
310-486-5677
A New York Stock Exchange Company Less

[L vus]

I just read your post in response to Ovidius. I agree with your post and would like to add that Dr Menon was my DD for investing in CT.. and NNVC. All the clinical testing for NNVC was done by Dr Menon and he signed off on all the results. Nobody wants to say anything about this fact that Dr Menon is in large part the reason NNVC will be a success, just like CT.. Dr Seymour is the CEO and had nothing to do with the science of NNVC. Ask Dr Menon about the CIDES.

L vus